Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Type of study
Language
Affiliation country
Publication year range
1.
Toxicol Lett ; 393: 1-13, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38219807

ABSTRACT

St. John's Wort preparations are used for the treatment of mild to moderate depression. They are usually well tolerated but can cause adverse reactions including liver toxicity in rare cases. To date, the mechanism(s) underlying the hepatotoxicity of St. John's Wort extracts are poorly investigated. We studied the hepatocellular toxicity of hypericin and hyperforin as the two main ingredients of St. John's Wort extracts in HepG2 and HepaRG cells and compared the effects to citalopram (a synthetic serotonin uptake inhibitor) with a special focus on mitochondrial toxicity and oxidative stress. In HepG2 cells, hypericin was membrane-toxic at 100 µM and depleted ATP at 20 µM. In HepaRG cells, ATP depletion started at 5 µM. In comparison, hyperforin and citalopram were not toxic up to 100 µM. In HepG2 cells, hypericin decreased maximal respiration starting at 2 µM and mitochondrial ATP formation starting at 10 µM but did not affect glycolytic ATP production. Hypericin inhibited the activity of complex I, II and IV of the electron transfer system and caused mitochondrial superoxide accumulation in cells. The protein expression of mitochondrial superoxide dismutase 2 (SOD2) and thioredoxin 2 (TRX2) and total and reduced glutathione decreased in cells exposed to hypericin. Finally, hypericin diminished the mitochondrial DNA copy number and caused cell necrosis but not apoptosis. In conclusion, hypericin, but not hyperforin or citalopram, is a mitochondrial toxicant at low micromolar concentrations. This mechanism may contribute to the hepatotoxicity occasionally observed in susceptible patients treated with St. John's Wort preparations.


Subject(s)
Anthracenes , Carcinoma, Hepatocellular , Chemical and Drug Induced Liver Injury , Hypericum , Liver Neoplasms , Perylene/analogs & derivatives , Phloroglucinol/analogs & derivatives , Terpenes , Humans , Plant Extracts/toxicity , Plant Extracts/therapeutic use , Hypericum/toxicity , Citalopram/toxicity , Carcinoma, Hepatocellular/drug therapy , Liver Neoplasms/drug therapy , Chemical and Drug Induced Liver Injury/drug therapy , Adenosine Triphosphate
SELECTION OF CITATIONS
SEARCH DETAIL